GE HealthCare today unveiled Freelium, a next-generation sealed magnet platform that aims to enable high-quality Magnetic Resonance (MR) imaging with less than 1% of helium used in conventional magnet technology.
Debuting at the European Congress of Radiology (ECR), Freelium marks the evolution of GE HealthCare’s lightweight intelligent platform magnet technology, which was first introduced in 2020, now with more than 2,000 installations worldwide at 1.5T and 3.0T magnetic fields.
Freelium is designed to significantly reduce liquid helium usage without compromising power efficiency and operational security. To maintain power efficiency, Freelium aims to operate with no additional cooling and power requirements. Additionally, the platform’s intelligent sensor technology intends to remotely monitor the MR system and enable automated magnet protection and recovery capability without the need for field engineer intervention. This is particularly important in the event of power outages or disruptions caused by natural events.
To support diagnostic accuracy and confidence, Freelium aims to uphold GE HealthCare’s advanced quality and performance standards. The platform also will be optimized to be compatible with GE HealthCare’s leading AI-enabled solutions. Freelium magnets will be able to be transported and installed in hospitals and in markets where access to helium is limited and without significant helium loss during transport, enhancing patient access to care.
With the Freelium platform, GE HealthCare is committed to achieving its sustainability goals by advancing environmentally conscious design from manufacturing and throughout the life cycle of the platform. Through the company’s intelligent magnet technology and Continuum™ upgrades, GE HealthCare has saved approximately 3 million liters of helium.
